BioSig Technologies (NASDAQ: BSGM)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-06-03 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of BioSig Technologies (NASDAQ: BSGM) through any online brokerage.
Other companies in BioSig Technologies’s space includes: Sonendo (NYSE:SONX), Second Sight Medical (NASDAQ:EYES), Pro-Dex (NASDAQ:PDEX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for BioSig Technologies (NASDAQ: BSGM) was reported by Roth Capital on Thursday, December 6, 2018. The analyst firm set a price target for 14.00 expecting BSGM to rise to within 12 months (a possible 1117.39% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BioSig Technologies (NASDAQ: BSGM) is $1.15 last updated May 20, 2022, 8:00 PM UTC.
There are no upcoming dividends for BioSig Technologies.
BioSig Technologies’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for BioSig Technologies.
BioSig Technologies is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.